Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjan Debnath

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Experimental Parasitology|June 16, 2005
Entamoeba histolytica: Characterization of human collagen type I and Ca2+ activated differentially expressed genesAnjan Debnath, Md Ali Akbar, Arindam Mazumder, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i>Abdolhakim Mohamed, John N Chilingerian, Prerna Bali, et al.
Plos Neglected Tropical Diseases|August 10, 2017
Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleriBharat Bashyal, Linfeng Li, Trpta Bains, et al.
Frontiers in Microbiology|June 2, 2015
Heat shock protein 90 inhibitors repurposed against Entamoeba histolyticaDea Shahinas, Anjan Debnath, Christan Benedict, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellaniiBrian Shing, Seema Singh, Larissa M Podust, et al.
Molecular Pharmacology|October 3, 2020
Domain-Swap Dimerization of <i>Acanthamoeba castellanii</i> CYP51 and a Unique Mechanism of Inactivation by IsavuconazoleVandna Sharma, Brian Shing, Lilian Hernandez-Alvarez, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasisJose Ignacio Escrig, Yukiko Miyamoto, Alejandro Delgado Aznar, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 11, 2019
Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and BalamuthiaMonica M Kangussu-Marcolino, Gretchen M Ehrenkaufer, Emily Chen, et al.
Experimental Parasitology|March 20, 2018
Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleriIngrid Zyserman, Deboprosad Mondal, Francisco Sarabia, et al.
Frontiers in Microbiology|March 22, 2018
<i>In Vitro</i> Efficacy of Ebselen and BAY 11-7082 Against <i>Naegleria fowleri</i>Anjan Debnath, Andrew T Nelson, Angélica Silva-Olivares, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Experimental Parasitology|June 16, 2005
Entamoeba histolytica: Characterization of human collagen type I and Ca2+ activated differentially expressed genesAnjan Debnath, Md Ali Akbar, Arindam Mazumder, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i>Abdolhakim Mohamed, John N Chilingerian, Prerna Bali, et al.
Plos Neglected Tropical Diseases|August 10, 2017
Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleriBharat Bashyal, Linfeng Li, Trpta Bains, et al.
Frontiers in Microbiology|June 2, 2015
Heat shock protein 90 inhibitors repurposed against Entamoeba histolyticaDea Shahinas, Anjan Debnath, Christan Benedict, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellaniiBrian Shing, Seema Singh, Larissa M Podust, et al.
Molecular Pharmacology|October 3, 2020
Domain-Swap Dimerization of <i>Acanthamoeba castellanii</i> CYP51 and a Unique Mechanism of Inactivation by IsavuconazoleVandna Sharma, Brian Shing, Lilian Hernandez-Alvarez, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasisJose Ignacio Escrig, Yukiko Miyamoto, Alejandro Delgado Aznar, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 11, 2019
Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and BalamuthiaMonica M Kangussu-Marcolino, Gretchen M Ehrenkaufer, Emily Chen, et al.
Experimental Parasitology|March 20, 2018
Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleriIngrid Zyserman, Deboprosad Mondal, Francisco Sarabia, et al.
Frontiers in Microbiology|March 22, 2018
<i>In Vitro</i> Efficacy of Ebselen and BAY 11-7082 Against <i>Naegleria fowleri</i>Anjan Debnath, Andrew T Nelson, Angélica Silva-Olivares, et al.
Pageof 7